Dimensional Fund Advisors
CCCC icon

Dimensional Fund Advisors’s C4 Therapeutics CCCC Stock Holding History

Dimensional Fund Advisors’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Buy
1,188,507
+745,989
+169% +$2.55M ﹤0.01% 2510
2026
Q1 		$1.16M Buy
442,518
+146,038
+49% +$344K ﹤0.01% 2817
2025
Q4 		$566K Sell
296,480
-52,809
-15% -$125K ﹤0.01% 2953
2025
Q3 		$775K Sell
349,289
-82,599
-19% -$198K ﹤0.01% 2928
2025
Q2 		$617K Sell
431,888
-82,267
-16% -$120K ﹤0.01% 2957
2025
Q1 		$823K Sell
514,155
-9,776
-2% -$29.2K ﹤0.01% 2913
2024
Q4 		$1.89M Sell
523,931
-54,954
-9% -$273K ﹤0.01% 2801
2024
Q3 		$3.3M Sell
578,885
-40,227
-6% -$242K ﹤0.01% 2655
2024
Q2 		$2.86M Sell
619,112
-12,979
-2% -$77.4K ﹤0.01% 2667
2024
Q1 		$5.16M Buy
632,091
+516,583
+447% +$4M ﹤0.01% 2538
2023
Q4 		$654K Sell
115,508
-67,117
-37% -$153K ﹤0.01% 3000
2023
Q3 		$340K Sell
182,625
-80,759
-31% -$246K ﹤0.01% 3115
2023
Q2 		$724K Sell
263,384
-118,832
-31% -$382K ﹤0.01% 2991
2023
Q1 		$1.2M Buy
+382,216
New +$2.25M ﹤0.01% 2864
2022
Q3 		$229K Buy
+26,078
New +$271K ﹤0.01% 3212

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors's CCCC Position: Q2 2026 in Review

Dimensional Fund Advisors increased its C4 Therapeutics (CCCC) stake by 169% in Q2 2026, buying an estimated $2.55M and bringing the position to 1,188,507 shares worth $5.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2510.

Dimensional Fund Advisors first reported a position in CCCC in Q3 2022 and has held it in 15 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Dimensional Fund Advisors held 1,188,507 shares of C4 Therapeutics worth $5.55M as of Q2 2026.
  • Dimensional Fund Advisors bought 745,989 C4 Therapeutics shares in Q2 2026, an estimated $2.55M.
  • C4 Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2510 holding.
  • Dimensional Fund Advisors first reported a position in C4 Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.